NEW YORK, May 8, 2023 /PRNewswire/ — Attention Relmada Therapeutics, Inc. (“Relmada” or the “Company”) (NASDAQ: RLMD) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Relmada and certain of its officers and directors regarding potential…